127 related articles for article (PubMed ID: 20942611)
1. Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin.
Huang X; Wu Z; Gao W; Chen Q; Yu B
Drug Dev Ind Pharm; 2011 Apr; 37(4):419-27. PubMed ID: 20942611
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
Wu W; Wang Y; Que L
Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
[TBL] [Abstract][Full Text] [Related]
3. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
4. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
Lu JJ; Wu ZH; Ping QN
Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
[TBL] [Abstract][Full Text] [Related]
5. Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.
Na M; Yiyun C; Tongwen X; Yang D; Xiaomin W; Zhenwei L; Zhichao C; Guanyi H; Yunyu S; Longping W
Eur J Med Chem; 2006 May; 41(5):670-4. PubMed ID: 16527374
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
7. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
Yanyu X; Yunmei S; Zhipeng C; Qineng P
Int J Pharm; 2006 Jan; 307(1):77-82. PubMed ID: 16300915
[TBL] [Abstract][Full Text] [Related]
8. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
Diaz C; Guzmán J; Jiménez VA; Alderete JB
Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
[TBL] [Abstract][Full Text] [Related]
9. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
Hussein A; El-Menshawe S; Afouna M
Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
Xiao YY; Song YM; Chen ZP; Ping QN
Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
15. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles.
Yu JN; Zhu Y; Wang L; Peng M; Tong SS; Cao X; Qiu H; Xu XM
Acta Pharmacol Sin; 2010 Jun; 31(6):759-64. PubMed ID: 20523347
[TBL] [Abstract][Full Text] [Related]
17. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.
Cheng Y; Qu H; Ma M; Xu Z; Xu P; Fang Y; Xu T
Eur J Med Chem; 2007 Jul; 42(7):1032-8. PubMed ID: 17336426
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
[TBL] [Abstract][Full Text] [Related]
19. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
[TBL] [Abstract][Full Text] [Related]
20. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
Cheng Y; Li M; Xu T
Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]